soul trial oral semaglutide cardiovascular outcomes results 2024 SOUL (Semaglutide cardiOvascular oUtcomes triaL) in individuals with 🧿 Oral semaglutide is the

Your GP may adjust dosing during heatwaves or recommend more aggressive hydration protocols

Patients should seek immediate medical attention if they experience chest pain, severe abdominal pain, persistent vomiting, signs of pancreatitis, or significant mood changes whilst taking these medications

Further population-based studies may quantify incidence rates, characterize dose-dependent relationships, and investigate mechanistic pathways to optimize risk stratification and therapeutic decision-making

Once approved, trained medical professionals like those at Leva Medical in Queens, NY may begin offering it as part of supervised weight-management programs

quarterly newsletter for health professionals